7Baggers
 Alector aims to seek FDA approval of Parkinson’s therapy in 2027  Parkinson's News Today Thu, 13 Nov 2025 14:05:45 GMT
 Mizuho Securities Keeps Their Hold Rating on Alector (ALEC)  The Globe and Mail Wed, 12 Nov 2025 08:00:00 GMT
 alector cuts costs and leans on partnerships for future growth  Finimize Sat, 08 Nov 2025 17:18:13 GMT
 william blair maintains alector(alec.us) with hold rating  富途牛牛 Sat, 08 Nov 2025 10:04:39 GMT
 Alector (ALEC) Reports Q3 Loss, Beats Revenue Estimates  sharewise.com Sat, 08 Nov 2025 07:21:02 GMT
 alector earnings beat by $0.06, revenue topped estimates  Investing.com Australia Fri, 07 Nov 2025 16:23:39 GMT
 alector clinical trial results townhall  AFTD - The Association for Frontotemporal Degeneration Fri, 07 Nov 2025 14:32:12 GMT
 Alector Cuts Costs And Leans On Partnerships For Future Growth  Finimize Fri, 07 Nov 2025 12:23:25 GMT
 william blair maintains alector(alec.us) with hold rating  富途牛牛 Fri, 07 Nov 2025 11:31:00 GMT
 Alector: Q3 Earnings Snapshot  theheraldreview.com Fri, 07 Nov 2025 10:37:17 GMT
 alector, inc. reports q3 2025 financial results  TipRanks Fri, 07 Nov 2025 05:45:40 GMT
 td cowen maintains alector(alec.us) with hold rating  富途牛牛 Fri, 07 Nov 2025 02:31:00 GMT
 Alector (ALEC) Q3 Revenue Falls Short; Focus Remains on Innovati  GuruFocus Fri, 07 Nov 2025 00:00:38 GMT
 clinical biotech firm alector q3 revenue beats expectations  MarketScreener Thu, 06 Nov 2025 22:27:49 GMT
 Alector Inc (ALEC) Q3 2025 Earnings: EPS Loss of $0.34 Beats Est  GuruFocus Thu, 06 Nov 2025 22:02:12 GMT
 did alector, inc. (alec) mislead investors? levi & korsinsky investigates  ACCESS Newswire Thu, 06 Nov 2025 19:36:31 GMT
 Alector (ALEC) Reports Q3 Loss, Beats Revenue Estimates  Yahoo Finance Thu, 06 Nov 2025 08:00:00 GMT
 Alector, Inc. Reports Q3 2025 Financial Results  TipRanks Thu, 06 Nov 2025 08:00:00 GMT
 Alector earnings beat by $0.06, revenue topped estimates  Investing.com Thu, 06 Nov 2025 08:00:00 GMT
 Alector reports Q3 EPS (34c), consensus (41c)  TipRanks Thu, 06 Nov 2025 08:00:00 GMT
 Alector: Q3 Earnings Snapshot  MarketScreener Thu, 06 Nov 2025 08:00:00 GMT
 alector faces critical juncture following clinical trial failure  AD HOC NEWS Wed, 05 Nov 2025 06:13:04 GMT

Alector, Inc
(NASDAQ:ALEC) 

ALEC stock logo

Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Park...

Founded: 2013
Full Time Employees: 162
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends